Immunopathogenesis of West Nile Virus infection
<p>The reappearance of West Nile virus (WNV) infection in last years has highlighted that arthropod-borne diseases are not circumscribed to tropical regions of the world. WNV is maintained in enzootic cycles involving, <em>Culex spp</em>. mosquitoes and avian hosts, with epizootic spread to mammals, including humans. Human infection results in mild symptomatic illness in 25% of cases or neurological disease in less than 1% of infected persons. Additional understandings on how WNV interacts with its hosts is recently growing; the virus exploits immune system, both at the peripheral tissues and the central nervous system, which could explain the differences in virulence, progression and severity of WNV infection. The continuing spread of WNV, combined with the lack of specific therapeutics or vaccines to combat or prevent infection, imparts a pressing need to identify the viral and host processes that control the outcome and immunity to WNV infection. Here, we provide an overview of a subset of information regarding the immune-pathological response generated during WNV infection.</p>